,article_id,Code,Date,Date_lag,Company,headline,orgs_mentioned,key_phrase,save_time,online_found
6352,720207,GSK.L,2000-11-01,2000-10-31, GSK;,"COMPANIES & FINANCE UK: Waiting and hoping for Santa to deliver the goods:
Jean-Pierre Garnier of GlaxoSmithKline is brimming with plans, once the FTC
signals its approval, reports David Pilling:", US Federal Trade Commission; FTC; SmithKline; US over-the-counter market; Glaxo; SB; GSK; Human Genome Sciences; Block Drug's Sensodyne; Block;,US Federal Trade Commission FTC SmithKline US over the counter market Glaxo SB GSK Human Genome Sciences Block Drug s Sensodyne Block,2023-03-31 10:33:27.919577,No
6353,732456,GSK.L,2001-01-05,2001-01-04, GSK;,COMPANIES & FINANCE UK: GSK receives first approval for Aids drug, European Union; European Commission; Glaxo Wellcome; SmithKline Beecham; GSK; US; US Federal Reserve; Glaxo; UK;,European Union European Commission Glaxo Wellcome SmithKline Beecham GSK US US Federal Reserve Glaxo UK,2023-03-31 10:33:39.736118,Yes
6354,741615,GSK.L,2001-02-19,2001-02-18, GSK;,"MARKETS WEEK FEBRUARY 19 - FEBRUARY 25: All eyes on first figures from
GlaxoSmithKline COMPANIES DIARY EDITED BY PETER JOHN:", Colt Telecom; Lloyds TSB; Equitable Life; US; GSK; Standard Chartered; Standard Trust UK; Chase Manhattan; Salomon Smith Barney; WPP; Young; Colt; UK; Wales; Hanson;,Colt Telecom Lloyds TSB Equitable Life US GSK Standard Chartered Standard Trust UK Chase Manhattan Salomon Smith Barney WPP Young Colt UK Wales Hanson,2023-03-31 10:33:46.493520,No
6355,742267,GSK.L,2001-02-22,2001-02-21, GSK;,"COMPANIES & FINANCE UK AND IRELAND: Buoyant GSK maintains momentum
PHARMACEUTICALS PROFITS AHEAD 11% DESPITE DISTRACTIONS OF MERGER:", Block Drug; US; Glaxo Wellcome; SmithKline Beecham; Goldman Sachs; US market; GSK;,Block Drug US Glaxo Wellcome SmithKline Beecham Goldman Sachs US market GSK,2023-03-31 10:33:52.904841,No
6356,742353,GSK.L,2001-02-23,2001-02-22, GSK;,"COMPANIES & FINANCE UK: Shake-up may be just what the doctor ordered: David
Pilling explains how re-engineered research should help GlaxoSmithKline produce
genomics-derived medicines:", Drug Discovery; Genetics Research and Discovery Research; GSK; Research Triangle Park; SB; Glaxo;,Drug Discovery Genetics Research and Discovery Research GSK Research Triangle Park SB Glaxo,2023-03-31 10:34:04.313370,Yes
6357,742533,GSK.L,2001-02-23,2001-02-22, GSK;,FRONT PAGE - COMPANIES & MARKETS: GSK plans six-way split for research, Pfizer; US; Glaxo; GSK;,Pfizer US Glaxo GSK,2023-03-31 10:34:10.656524,No
6358,745942,GSK.L,2001-03-13,2001-03-12, GSK;,SHORTS: Tobacco chief to quit GSK post, Tobacco; GSK; Imperial Tobacco;,Tobacco GSK Imperial Tobacco,2023-03-31 10:34:22.335697,Yes
6359,753189,GSK.L,2001-04-18,2001-04-17, GSK;,"COMPANIES & FINANCE UK: GSK in marketing blitz to promote drug PHARMACEUTICALS
US LAUNCH OF ASTHMA MEDICINE WILL BE IMPORTANT TEST FOR ANGLO-AMERICAN GROUP:", US; Glaxo Wellcome; SmithKline Beecham; Glaxo; SmithKline; GSK; Merck;,US Glaxo Wellcome SmithKline Beecham Glaxo SmithKline GSK Merck,2023-03-31 10:34:28.909803,No
6360,760497,GSK.L,2001-05-22,2001-05-21, GSK;,GSK still hopes Lotronex can be sold, Glaxo Wellcome; SmithKline Beecham; GSK; Abbott Laboratories; Bristol-Myers Squibb and Merck; US; Merck; Huntingdon Life Sciences;,Glaxo Wellcome SmithKline Beecham GSK Abbott Laboratories Bristol Myers Squibb and Merck US Merck Huntingdon Life Sciences,2023-03-31 10:34:35.678641,No
6361,761296,GSK.L,2001-05-25,2001-05-24, GSK;,First casualty at GSK as Glaxo executive quits, Glaxo; GSK; Duke University; US; SmithKline Beecham;,Glaxo GSK Duke University US SmithKline Beecham,2023-03-31 10:34:47.318801,Yes
6362,763991,GSK.L,2001-06-08,2001-06-07, GSK;,GSK faces patents challenge in US, GSK; US  GlaxoSmithKline; US;,GSK US GlaxoSmithKline US,2023-03-31 10:34:58.993470,Yes
6363,773726,GSK.L,2001-07-25,2001-07-24, GSK;,GlaxoSmithKline shows that size does matter, Glaxo Wellcome; SmithKline Beecham; US; GSK;,Glaxo Wellcome SmithKline Beecham US GSK,2023-03-31 10:35:18.556319,Yes
6364,773832,GSK.L,2001-07-25,2001-07-24, GSK;,GlaxoSmithKline LEX COLUMN, US; GSK; Pfizer; Eli Lilly; Merck;,US GSK Pfizer Eli Lilly Merck,2023-03-31 10:35:24.959081,No
6365,774786,GSK.L,2001-07-31,2001-07-30, GSK;,GSK to give away stake in drug group, US; Patricof & Co; GSK; Sprout Group; MPM Asset Management and Apax Partners; Lehman Brothers;,US Patricof Co GSK Sprout Group MPM Asset Management and Apax Partners Lehman Brothers,2023-03-31 10:35:31.496564,No
6366,782641,GSK.L,2001-09-12,2001-09-11, GSK;,GSK in joint research deal with Tanabe, UK; GSK; ING Barings;,UK GSK ING Barings,2023-03-31 10:35:43.015281,Yes
6367,783171,GSK.L,2001-09-13,2001-09-12, GSK;,Authorities in Germany probe GSK's Zyban PHARMACEUTICALS:, Federal Institute for Drugs and Medical Devices; Erfurt Institute for Nicotine; US; GSK; UK Department of Health; US Food and Drug Administration; American Home Products; Bayer;,Federal Institute for Drugs and Medical Devices Erfurt Institute for Nicotine US GSK UK Department of Health US Food and Drug Administration American Home Products Bayer,2023-03-31 10:35:49.736544,No
6368,791343,GSK.L,2001-10-24,2001-10-23, GSK;,"GSK shows benefit of drugs in downturn PHARMACEUTICALS PROFITS RISE AND SHARE
BUY-BACK TO ENHANCE EARNINGS HIGHLIGHT SECTOR'S STATUS AS SAFE HAVEN:", Glaxo Wellcome; Smithkline Beecham; US; GSK;,Glaxo Wellcome Smithkline Beecham US GSK,2023-03-31 10:36:01.250138,Yes
6369,799104,GSK.L,2001-11-30,2001-11-29, GSK;,"Wellcome Trust sells Pounds 1.8bn holding in GSK PHARMACEUTICALS CHARITY ENDS
SPECIAL RELATIONSHIP BUT INTENDS TO RETAIN REDUCED STAKE:", Wellcome Trust; Salomon Smith Barney; GSK; Wellcome Foundation; Glaxo; Glaxo Wellcome;,Wellcome Trust Salomon Smith Barney GSK Wellcome Foundation Glaxo Glaxo Wellcome,2023-03-31 10:36:07.827840,No
6370,801435,GSK.L,2001-12-12,2001-12-11, GSK;,GSK in record Pounds 1bn offering, UK; Procter & Gamble; UPS; Salomon Smith Barney; GSK; France Telecom; General Motors;,UK Procter Gamble UPS Salomon Smith Barney GSK France Telecom General Motors,2023-03-31 10:36:19.580825,Yes
6371,806678,GSK.L,2002-01-16,2002-01-15, GSK;,"Curtain falls on difficult year for GSK: The developing world's infringement of
patents on HIV drugs marked a low point for the company, writes Patrick Jenkins:", GSK; Merck; Pfizer; HIV;,GSK Merck Pfizer HIV,2023-03-31 10:36:31.353179,Yes
6372,808424,GSK.L,2002-01-25,2002-01-24, GSK;,GSK considers research spin-offs, GSK;,GSK,2023-03-31 10:36:42.824558,Yes
6373,812671,GSK.L,2002-02-15,2002-02-14, GlaxoSmithKline;,MMR vaccine defended by GSK NEWS DIGEST:, GSK  GlaxoSmithKline; MMR; Medical Research Council;,GSK GlaxoSmithKline MMR Medical Research Council,2023-03-31 10:36:49.221889,No
6374,815749,GSK.L,2002-03-04,2002-03-03, GSK;,"GSK to appeal against US court ruling PHARMACEUTICALS GROUP FACES SETBACK AFTER
PATENT DECISION FAVOURS ANDRX:", US; GSK; US District Court; Eli Lilly and Bristol-Myers Squibb;,US GSK US District Court Eli Lilly and Bristol Myers Squibb,2023-03-31 10:36:55.633852,No
6375,821485,GSK.L,2002-04-03,2002-04-02, GSK;,"GSK has Pounds 457m 'notional' pension deficit PHARMACEUTICALS NEW ACCOUNTING
STANDARD REVEALS SHORTFALL: * CHIEF EXECUTIVE BECOMES ONE OF HIGHEST-PAID UK
BOSSES:", Accounting Standards Board; Glaxo Wellcome; SmithKline Beecham; GSK; Pfizer; Merck;,Accounting Standards Board Glaxo Wellcome SmithKline Beecham GSK Pfizer Merck,2023-03-31 10:37:07.410500,Yes
6376,824004,GSK.L,2002-04-16,2002-04-15, GSK;,"GSK pays Dollars 420m for two drugs PHARMACEUTICALS GROUP HAS SUGGESTED IT IS
'NOT INTERESTED IN A NEW MERGER':", GSK; Unigene Laboratories; US; LG Chem Investments; Food and Drug Administration; Bristol-Myers Squibb; Bayer;,GSK Unigene Laboratories US LG Chem Investments Food and Drug Administration Bristol Myers Squibb Bayer,2023-03-31 10:37:19.176765,Yes
6377,825882,GSK.L,2002-04-25,2002-04-24, GSK;,GlaxoSmithKline LEX COLUMN, GSK; US;,GSK US,2023-03-31 10:37:30.568952,Yes
6378,825886,GSK.L,2002-04-25,2002-04-24, GSK;,"Investors still worry about GSK's weight: Strong earnings growth fails to
reassure the market about the health of the pharmaceutical giant, says Geoff
Dyer:", GSK; Bayer; US; Glaxo; Pfizer; Bank Julius Baer;,GSK Bayer US Glaxo Pfizer Bank Julius Baer,2023-03-31 10:37:46.727135,Yes
6379,830971,GSK.L,2002-05-23,2002-05-22, GSK;,"GSK in Dollars 283m deal for diabetes drug PHARMACEUTICALS ANALYSTS SAY NOBEX
TABLET IS REVOLUTIONARY AND HAS POTENTIAL TO BE A 'BLOCKBUSTER':", US; Unigene Laboratories; Bayer; GSK;,US Unigene Laboratories Bayer GSK,2023-03-31 10:37:53.134790,No
6380,831558,GSK.L,2002-05-24,2002-05-23, GSK;,Judge rules GSK patents invalid NEWS DIGEST, US; GSK;,US GSK,2023-03-31 10:38:05.053555,Yes
6381,831873,GSK.L,2002-05-27,2002-05-26, GSK;,Retiring chairman optimistic on GSK, Glaxo Wellcome; SmithKline Beecham; US; Imperial College London; Deutsche Bank; GSK; Deutsche.;,Glaxo Wellcome SmithKline Beecham US Imperial College London Deutsche Bank GSK Deutsche,2023-03-31 10:38:11.547287,No
6382,834327,GSK.L,2002-06-10,2002-06-09, GSK;,"Pressure on the patents pipeline: With GlaxoSmithKline's share price suffering,
Patrick Jenkins wonders if another merger could be on the cards:"," US,; US Food and Drug Administration; Bayer; Bristol-Myers Squibb; US; Glaxo; SmithKline Beecham; GSK;",US US Food and Drug Administration Bayer Bristol Myers Squibb US Glaxo SmithKline Beecham GSK,2023-03-31 10:38:18.105717,No
6383,835082,GSK.L,2002-06-13,2002-06-12, GSK;,Fears over tax bill fade at GSK, US; US Internal Revenue Service; Glaxo Wellcome; IRS; GSK; Deloitte & Touche; UK;,US US Internal Revenue Service Glaxo Wellcome IRS GSK Deloitte Touche UK,2023-03-31 10:38:29.692263,Yes
6384,836739,GSK.L,2002-06-21,2002-06-20, GlaxoSmithKline;,GlaxoSmithKline NEWS DIGEST:, US;,US,2023-03-31 10:38:46.116461,Yes
6385,841519,GSK.L,2002-07-17,2002-07-16, GSK;,GSK hurt by worries on prospects PHARMACEUTICALS GROUP SHARES FALL:, Pfizer; US; GSK; Bristol-Myers Squibb; Lehman Brothers;,Pfizer US GSK Bristol Myers Squibb Lehman Brothers,2023-03-31 10:38:52.673349,No
6386,842371,GSK.L,2002-07-22,2002-07-21, GSK;,GSK chief is top of pay league, GSK;,GSK,2023-03-31 10:41:06.815642,Yes
6387,842475,GSK.L,2002-07-22,2002-07-21, GSK;,GSK moves to allay fears over strategy PHARMACEUTICALS:, SmithKline Beecham; US; Eli Lilly; GSK; Pfizer;,SmithKline Beecham US Eli Lilly GSK Pfizer,2023-03-31 10:41:18.076751,Yes
6388,843153,GSK.L,2002-07-25,2002-07-24, GSK;,GlaxoSmithKline LEX COLUMN, Merck; GSK; Pfizer; US;,Merck GSK Pfizer US,2023-03-31 10:41:29.339805,Yes
6389,850565,GSK.L,2002-09-06,2002-09-05, GSK;,GSK cuts its drug prices for poor countries, United Nations-sponsored Global Fund; Merck; US; GSK; UK; AZT;,United Nations sponsored Global Fund Merck US GSK UK AZT,2023-03-31 10:41:35.740433,No
6390,852937,GSK.L,2002-09-19,2002-09-18, GSK;,GSK facing Indian threat, US; GSK; International Trade Commission;,US GSK International Trade Commission,2023-03-31 10:41:47.674213,Yes
6391,854614,GSK.L,2002-09-27,2002-09-26, GSK;,GSK drug wins approval NEWS DIGEST, US; Food and Drug Administration; GSK; US of Pounds;,US Food and Drug Administration GSK US of Pounds,2023-03-31 10:41:54.023095,No
6392,859516,GSK.L,2002-10-22,2002-10-21, GSK;,"Departure of senior GSK scientists continues: Pharmaceutical group's head of
development is to run the research department at Bristol-Myers", Bristol-Myers Squibb; SmithKline Beecham; Bristol; US; Bristol.; GSK; ING; Glaxo; Bristol's;,Bristol Myers Squibb SmithKline Beecham Bristol US Bristol GSK ING Glaxo Bristol s,2023-03-31 10:42:05.595282,Yes
6393,859565,GSK.L,2002-10-22,2002-10-21, GSK;,GSK may join bidding for embattled PowderJect, US; GSK;,US GSK,2023-03-31 10:42:18.346891,Yes
6394,859986,GSK.L,2002-10-24,2002-10-23, GSK;,"GlaxoSmithKline's radical programme to increase the productivity of its 15,000
scientists is a test case for the entire drugs industry. But progress is slow,
writesGeoff Dyer", SmithKline Beecham; GSK; Deutsche Bank; SmithKline; LG Chemical; Glaxo; Research; Bristol-Myers Squibb; US; Merck;,SmithKline Beecham GSK Deutsche Bank SmithKline LG Chemical Glaxo Research Bristol Myers Squibb US Merck,2023-03-31 10:42:30.270894,Yes
6395,865196,GSK.L,2002-11-19,2002-11-18, GSK;,"GSK investors set to fight doubling of chief's package: Drugs group's chairman
seeks to head off opposition over latest entitlement", UK; Association of British Insurers; GSK; US; Glaxo; Pfizer and Merck;,UK Association of British Insurers GSK US Glaxo Pfizer and Merck,2023-03-31 10:42:41.535051,Yes
6396,865964,GSK.L,2002-11-22,2002-11-21, GSK;,Anger rising over pay package for GSK chief, UK; Glaxo; SmithKline; Association of British Insurers; Enron; GSK;,UK Glaxo SmithKline Association of British Insurers Enron GSK,2023-03-31 10:42:52.800920,Yes
6397,866607,GSK.L,2002-11-25,2002-11-24, GSK;,GSK in retreat on Garnier's Dollars 18m deal, GSK; National Association of; Association of British Insurers; Insight Investment Management; Legal; US;,GSK National Association of Association of British Insurers Insight Investment Management Legal US,2023-03-31 10:43:04.061499,Yes
6398,868209,GSK.L,2002-12-04,2002-12-03, GSK;,GSK setback on drug ruling NEWS DIGEST, High Court; UK; Glaxo Wellcome; GSK;,High Court UK Glaxo Wellcome GSK,2023-03-31 10:43:15.738600,Yes
6399,868495,GSK.L,2002-12-05,2002-12-04, GSK;,GSK plans IT outsourcing NEWS DIGEST, GSK;,GSK,2023-03-31 10:43:22.016624,No
6400,872924,GSK.L,2002-12-31,2002-12-30, GSK;,"GSK secures legal respite over Paxil PATENT VICTORY LEAVES PHARMACEUTICALS GROUP
UPBEAT ON FUTURE EARNINGS: * RULING MAY SIGNAL CHANGE IN JUDICIAL SENTIMENT:", US; Lehman Brothers; GSK;,US Lehman Brothers GSK,2023-03-31 10:43:28.255141,No
6401,878312,GSK.L,2003-01-30,2003-01-29, GSK;,Revamp at GSK shows 'first signs of success', Deutsche Bank; GSK; SmithKline Beecham; US Food and Drug Administration;,Deutsche Bank GSK SmithKline Beecham US Food and Drug Administration,2023-03-31 10:43:39.908612,Yes
6402,880243,GSK.L,2003-02-10,2003-02-09, GSK;,"GSK aims to boost earnings for 700 top staff: Company argues that better
remuneration packages are needed to compete with rivals in US", GSK; US; Pfizer and Merck; Deutsche Bank;,GSK US Pfizer and Merck Deutsche Bank,2023-03-31 10:43:51.269259,Yes
6403,880723,GSK.L,2003-02-11,2003-02-10, GSK;,GSK faces up to fresh generic drug challenges, US; Food & Drug Administration; Lehman Brothers; GSK;,US Food Drug Administration Lehman Brothers GSK,2023-03-31 10:44:02.830445,Yes
6404,880902,GSK.L,2003-02-13,2003-02-12, GSK;,"GSK injects Pounds 320m into pension fund: Group scheme's increasing shortfall
recorded at Pounds 1.3bn by end of 2002", GSK; Group;,GSK Group,2023-03-31 10:44:14.716021,Yes
6405,884632,GSK.L,2003-03-05,2003-03-04, GSK;,GSK MARTIN DICKSON - LOMBARD, GSK; Goldman Sachs; Deutsche Bank; Glaxo Wellcome/SmithKline Beecham;,GSK Goldman Sachs Deutsche Bank Glaxo Wellcome SmithKline Beecham,2023-03-31 10:44:26.189296,Yes
6406,884716,GSK.L,2003-03-05,2003-03-04, GSK;,"GSK loses patent case over best-selling drug: Decision opens way for Apotex to
launch generic version of anti-depressant", US; GSK;,US GSK,2023-03-31 10:44:37.454307,Yes
6407,891825,GSK.L,2003-04-10,2003-04-09, GSK;,"GSK set back by judge's ruling on antibiotic: Drugs group loses first round in
claim over stolen bacteria", US; GSK; International Trade Commission; ITC;,US GSK International Trade Commission ITC,2023-03-31 10:44:48.608855,Yes
6408,891772,GSK.L,2003-04-10,2003-04-09, GlaxoSmithKline;,Setback for GSK, GSK  GlaxoSmithKline; US;,GSK GlaxoSmithKline US,2023-03-31 10:44:59.674391,Yes
6409,893064,GSK.L,2003-04-16,2003-04-15, GSK;,GSK urged to evaluate Aids drug licensing PHARMACEUTICALS:, California Public Employees; GSK; European Commission; Commission; US;,California Public Employees GSK European Commission Commission US,2023-03-31 10:45:13.807647,Yes
6410,893135,GSK.L,2003-04-16,2003-04-15, GSK;,GSK urged to change stance on Aids drugs, California Public Employees; GSK;,California Public Employees GSK,2023-03-31 10:45:25.069775,Yes
6411,894686,GSK.L,2003-04-28,2003-04-27, GSK;,GSK cuts price of top Aids treatment By Geoff Dyer, World Health Organisation; GSK; US; European Commission;,World Health Organisation GSK US European Commission,2023-03-31 10:45:36.346384,Yes
6412,894715,GSK.L,2003-04-28,2003-04-27, GSK;,"GSK bows to pressure and halves price of top Aids drug: Second cut in seven
months could benefit patients in 63 developing countries By Geoff Dyer", World Health Organisation; GSK; US; European Commission;,World Health Organisation GSK US European Commission,2023-03-31 10:45:47.801610,Yes
6413,896648,GSK.L,2003-05-06,2003-05-05, GSK;,UK: GSK 'could pay Garnier Dollars 35m in golden farewell', Pensions Investment and Research Consultancy; GSK; Association of British Insurers;,Pensions Investment and Research Consultancy GSK Association of British Insurers,2023-03-31 10:45:53.985134,No
6414,896790,GSK.L,2003-05-08,2003-05-07, GSK;,GSK faces fresh challenge, GSK; US;,GSK US,2023-03-31 10:46:00.070001,No
6415,897536,GSK.L,2003-05-12,2003-05-11, GSK;,UK: GSK proposes boardroom changes to deflect critics PHARMACEUTICALS:, Association of British Insurers; UK; Xerox; Reuters; GSK; Touche; National Association of Pension Funds;,Association of British Insurers UK Xerox Reuters GSK Touche National Association of Pension Funds,2023-03-31 10:46:06.210602,No
6416,898932,GSK.L,2003-05-20,2003-05-19, GSK;,Parachute holed: GSK must respond to shareholder concerns on executive pay," SmithKline; GSK; US; UK ""; Financial Times;",SmithKline GSK US UK Financial Times,2023-03-31 10:46:12.267698,No
6417,899056,GSK.L,2003-05-20,2003-05-19, GSK;,Another fat cat at GSK's door PHARMACEUTICALS:, Aids; Healthcare Foundation; GSK; UK Shareholders Association; SmithKline Beecham;,Aids Healthcare Foundation GSK UK Shareholders Association SmithKline Beecham,2023-03-31 10:46:23.646931,Yes
6418,899361,GSK.L,2003-05-21,2003-05-20, GSK;,"After Garnier: why executive rewards in the US and the UK are unlikely to
converge: British companies that want to compete for American talent must
combine two remuneration cultures. The controversy at GlaxoSmithKline and
elsewhere suggests the divide may never fully close, writes Michael Skapinker:", US; Pensions Investment Research Consultants; UK; HSBC; HSBC Group; UK's National Association of; Reuters; Royal & Sun Alliance; Conservative; General Electric; GE; Watson Wyatt; Corporate Library; Bell; GSK; Enron; Association of British Insurers; Institutional Shareholder Services; Securities and Exchange Commission; Global Advisors;,US Pensions Investment Research Consultants UK HSBC HSBC Group UK s National Association of Reuters Royal Sun Alliance Conservative General Electric GE Watson Wyatt Corporate Library Bell GSK Enron Association of British Insurers Institutional Shareholder Services Securities and Exchange Commission Global Advisors,2023-03-31 10:46:35.315911,Yes
6419,899433,GSK.L,2003-05-21,2003-05-20, GSK;,GSK faces more flak, GSK;,GSK,2023-03-31 10:46:47.193941,Yes
6420,902358,GSK.L,2003-06-06,2003-06-05, GSK;,Xerox deal hits GSK, Xerox; GSK; US;,Xerox GSK US,2023-03-31 10:46:53.206082,No
6421,902516,GSK.L,2003-06-06,2003-06-05, GSK;,GSK hit by Dollars 22m Xerox pay-out, US; Xerox; Securities and Exchange Commission; GSK; Prudential; Harvard Business School; SEC; KPMG;,US Xerox Securities and Exchange Commission GSK Prudential Harvard Business School SEC KPMG,2023-03-31 10:46:59.420280,No
6422,903158,GSK.L,2003-06-10,2003-06-09, GSK;,GSK faces Paxil grilling, GSK;,GSK,2023-03-31 10:47:10.604739,Yes
6423,905097,GSK.L,2003-06-18,2003-06-17, GSK;,GSK reopens talks on executive pay, UK; GSK;,UK GSK,2023-03-31 10:47:16.604829,No
6424,906335,GSK.L,2003-06-27,2003-06-26, GSK;,GSK wins case against generic drugs PHARMACEUTICALS:, US; FDA; UK; GSK;,US FDA UK GSK,2023-03-31 10:47:22.614773,No
6425,909427,GSK.L,2003-07-11,2003-07-10, GSK;,GSK and Novartis settle trade dispute PHARMACEUTICALS:, GSK; US; International Trade Commission; Novartis;,GSK US International Trade Commission Novartis,2023-03-31 10:47:28.685870,No
6426,911550,GSK.L,2003-07-24,2003-07-23, GSK;,GSK upgrades forecast on strong bottom line PHARMACEUTICALS:, Touche; GSK; UK; US;,Touche GSK UK US,2023-03-31 10:47:34.695848,No
6427,919721,GSK.L,2003-09-10,2003-09-09, GSK;,GSK faces generic rival, GSK;,GSK,2023-03-31 10:47:45.885554,Yes
6428,919916,GSK.L,2003-09-10,2003-09-09, GSK;,GSK patents face fresh generics challenges, US; GSK; US of;,US GSK US of,2023-03-31 10:47:57.027682,Yes
6429,922605,GSK.L,2003-09-24,2003-09-23, GSK;,GSK policy aims to restrict pay-offs after radical review, Association of British Insurers; National Association of; AGM; GSK; SmithKline Beecham;,Association of British Insurers National Association of AGM GSK SmithKline Beecham,2023-03-31 10:48:08.294158,Yes
6430,928723,GSK.L,2003-10-23,2003-10-22, GSK;,GSK unveils Indian research tie-up as sales rise PHARMACEUTICALS:, US; GSK;,US GSK,2023-03-31 10:48:19.457727,Yes
6431,928928,GSK.L,2003-10-23,2003-10-22, GSK;,GSK in Indian drugs link-up, US; GSK; Morgan Stanley; US Food and Drug Administration; FDA;,US GSK Morgan Stanley US Food and Drug Administration FDA,2023-03-31 10:48:25.602200,No
6432,935819,GSK.L,2003-11-25,2003-11-24, GSK;,GSK loses appeal on Novartis ruling, US; Swiss; GSK;,US Swiss GSK,2023-03-31 10:48:31.685719,No
6433,936202,GSK.L,2003-11-27,2003-11-26, GSK;,UK: Wellbutrin generic launch hits GSK, Eon Labs; US; US Food and Drug Administration; GSK;,Eon Labs US US Food and Drug Administration GSK,2023-03-31 10:48:37.762992,No
6434,936882,GSK.L,2003-12-01,2003-11-30, GSK;,GlaxoSmithKline THE LEX COLUMN:, GSK;,GSK,2023-03-31 10:48:49.360472,Yes
6435,936887,GSK.L,2003-12-01,2003-11-30, GSK;,GSK seeks to win investor confidence in drug research, Goldman Sachs; GSK; ING Barings;,Goldman Sachs GSK ING Barings,2023-03-31 10:49:00.560383,Yes
6436,937675,GSK.L,2003-12-04,2003-12-03, GSK;,"Jury still out on GSK's claims of having 'best pipeline in industry':
PHARMACEUTICALS: The financial expectations of the company's drugs under
development were announced yesterday. Geoff Dyer and David Firn report on the
reaction from investors", Glaxo Wellcome; SmithKline Beecham; GSK; Lehman Brothers;,Glaxo Wellcome SmithKline Beecham GSK Lehman Brothers,2023-03-31 10:49:06.641988,No
6437,939616,GSK.L,2003-12-15,2003-12-14, GSK;,Dollars 10m salary for GSK head, GSK;,GSK,2023-03-31 10:49:18.652415,Yes
6438,939623,GSK.L,2003-12-15,2003-12-14, GSK;,UK: GSK chief to be paid up to Dollars 10m PHARMACEUTICALS:, Association of British Insurers; ABI; AGM; GSK; National Association of Pension Funds;,Association of British Insurers ABI AGM GSK National Association of Pension Funds,2023-03-31 10:49:29.910092,Yes
6439,939996,GSK.L,2003-12-16,2003-12-15, GSK;,UK: Support for new pay deal for GSK chief PHARMACEUTICALS:, Association of British Insurers; National Association of Pension Funds; GSK; Morley Fund Management; UK; Insight Investments; ABI;,Association of British Insurers National Association of Pension Funds GSK Morley Fund Management UK Insight Investments ABI,2023-03-31 10:49:36.109795,No
6440,939997,GSK.L,2003-12-16,2003-12-15, GSK;,"UK: Mid-Atlantic Man straddles the great divide: GlaxoSmithKline's new pay
package LOMBARD MARTIN DICKSON", GSK; UK; US;,GSK UK US,2023-03-31 10:49:47.359917,Yes
6441,943030,GSK.L,2004-01-08,2004-01-07, GSK;,GSK vows to fight US tax demand for extra Dollars 5.2bn, US Internal Revenue Service; GSK; IRS; US Tax Court; US; Glaxo; Glaxo Wellcome; UK Inland Revenue; Lehman Brothers;,US Internal Revenue Service GSK IRS US Tax Court US Glaxo Glaxo Wellcome UK Inland Revenue Lehman Brothers,2023-03-31 10:49:53.796261,No
6442,961711,GSK.L,2004-04-14,2004-04-13, GSK;,GSK buys heart disease drugs and Sanofi plant, GSK; Code Securities;,GSK Code Securities,2023-03-31 10:50:00.170023,No
6443,965252,GSK.L,2004-04-30,2004-04-29, GSK;,GSK to stay unaffected by merger round PHARMACEUTICALS:, GSK; US;,GSK US,2023-03-31 10:50:06.555387,No
6444,966069,GSK.L,2004-05-04,2004-05-03, GSK;,"GSK: a delicate tweaking of board machinery: Chairman responds to investor
pressures MARTIN DICKSON LOMBARD", GSK; SmithKline Beecham; US; UK; Enron; Harvard Business School; Harvard Business School Press;,GSK SmithKline Beecham US UK Enron Harvard Business School Harvard Business School Press,2023-03-31 10:50:22.917419,Yes
6445,965833,GSK.L,2004-05-05,2004-05-04, GSK;,ABI in warning to GSK over pay, Association of British Insurers; ABI; UK; GSK; Investment Research Consultants;,Association of British Insurers ABI UK GSK Investment Research Consultants,2023-03-31 10:50:34.320507,Yes
6446,968263,GSK.L,2004-05-17,2004-05-16, GSK;,GSK rebuilds confidence after pay setback PHARMACEUTICALS:, GSK; Reuters; US; Association of British Insurers; UK;,GSK Reuters US Association of British Insurers UK,2023-03-31 10:50:40.695318,No
6447,968322,GSK.L,2004-05-17,2004-05-16, GSK;,Gent lined up to take chairman's job at GSK, GSK; Harvard Business School; US; United Nations;,GSK Harvard Business School US United Nations,2023-03-31 10:50:47.186283,No
6448,968566,GSK.L,2004-05-18,2004-05-17, GSK;,Pay policy change prevents GSK investor rebellion PHARMACEUTICALS:, GSK; Investment Research Consultants;,GSK Investment Research Consultants,2023-03-31 10:50:58.643773,Yes
6449,970300,GSK.L,2004-05-27,2004-05-26, GSK;,Gent faces bridge-building at GSK PHARMACEUTICALS:, GSK; UK; Merck; Pfizer; Morley Fund Management; US;,GSK UK Merck Pfizer Morley Fund Management US,2023-03-31 10:51:05.010912,No
6450,971617,GSK.L,2004-06-03,2004-06-02, GSK;,"GSK suit reopens furore over SSRIs: The controversial anti-depressants have
sparked a debate over how drugs groups publish research, say Geoff Dyer
andChristopher Bowe", GSK; US; Eli Lilly; Prozac.; Food and Drug Administration; FDA; Canadian Medical Association; European Medical;,GSK US Eli Lilly Prozac Food and Drug Administration FDA Canadian Medical Association European Medical,2023-03-31 10:51:16.712662,Yes
6451,971656,GSK.L,2004-06-03,2004-06-02, GSK;,"Spitzer hits GSK with child-drug lawsuit: New York attorney-general claims
pharmaceuticals giant concealed research on antidepressant effects", GSK; Paxil; US; US Food and Drug Administration; FDA; Alston;,GSK Paxil US US Food and Drug Administration FDA Alston,2023-03-31 10:51:23.133018,No
6452,976245,GSK.L,2004-06-28,2004-06-27, GSK;,GSK's gifts push up charitable donations by 6% CORPORATE SUPPORT:, GSK; Charity Trends; Charities Aid Foundation; CAF; Lloyds TSB; World Health Organisation; National Health Service;,GSK Charity Trends Charities Aid Foundation CAF Lloyds TSB World Health Organisation National Health Service,2023-03-31 10:51:29.669448,No
6453,987286,GSK.L,2004-08-27,2004-08-26, GSK;,"GSK pays Pounds 1.4m in Spitzer suit: Drugs group to publish all research
results as part of deal: * Alleged cases of suppression of negative trial
results to be investigated", New York state; GSK; Forest Laboratories; US;,New York state GSK Forest Laboratories US,2023-03-31 10:51:36.160817,No
6454,988017,GSK.L,2004-08-31,2004-08-30, GSK;,Spitzer sounds further warning to GSK, GSK; US;,GSK US,2023-03-31 10:51:47.848537,Yes
6455,988777,GSK.L,2004-09-07,2004-09-06, GSK;,GSK faces drug claim in US NEWS DIGEST, US; GSK;,US GSK,2023-03-31 10:51:54.153705,No
6456,993006,GSK.L,2004-10-05,2004-10-04, GSK;,"A bigger bowl of cream for the not so fat cats: Non-executive pay at
GlaxoSmithKline MARTIN DICKSON LOMBARD", KPMG; GSK; UK; Enron; Independent Remuneration Solutions;,KPMG GSK UK Enron Independent Remuneration Solutions,2023-03-31 10:52:05.861269,Yes
6457,993084,GSK.L,2004-10-05,2004-10-04, GSK;,"GSK to boost non-execs' pay: Investors fear directors' independence may be
compromised: * Company used 'benchmark' measure to help it justify increases", UK; GSK; US;,UK GSK US,2023-03-31 10:52:17.336683,Yes
6458,997072,GSK.L,2004-10-29,2004-10-28, GSK;,GSK lower but shedding generic drag PHARMACEUTICALS:, European Court of Justice; EU; US; GSK; Glaxo Wellcome/SmithKline Beecham; Merck;,European Court of Justice EU US GSK Glaxo Wellcome SmithKline Beecham Merck,2023-03-31 10:52:23.753160,No
6459,1007330,GSK.L,2005-01-10,2005-01-09, GSK;,GSK launches Euros 5m NiQuitin marketing drive ITALY:, Pfizer; GSK;,Pfizer GSK,2023-03-31 10:52:35.277007,Yes
6460,1010154,GSK.L,2005-01-27,2005-01-26, GSK;,"GSK tax bill raised to Dollars 7.8bn: US revenue service escalates back-payments
battle over transfer pricing: * Additional demand of Dollars 1.9bn to cover
Zantac profits", US Internal Revenue Service; IRS; GSK; US; Deutsche Bank; Glaxo Wellcome; Eli Lilly;,US Internal Revenue Service IRS GSK US Deutsche Bank Glaxo Wellcome Eli Lilly,2023-03-31 10:52:41.826148,No
6461,1016231,GSK.L,2005-03-07,2005-03-06, GSK;,Modest pay cut for GSK chief after 8% fall in bonus," GSK; 78,000;",GSK,2023-03-31 10:52:48.097530,No
6462,1018301,GSK.L,2005-03-18,2005-03-17, GSK;,"Glaxo's catalyst for creativity: FT SERIES: REFORMING EUROPE CORPORATE
EFFICIENCY: GSK's Stevenage site shows how the drugs group has reshaped itself
to tackle a sector-wide fall in products under development, writes Andrew Jack", Pentagon; European Union; US; GSK; Glaxo Wellcome; SmithKline Beecham; GSK Biologicals; CEDD; GCSE;,Pentagon European Union US GSK Glaxo Wellcome SmithKline Beecham GSK Biologicals CEDD GCSE,2023-03-31 10:52:59.836791,Yes
6463,1019907,GSK.L,2005-03-30,2005-03-29, GSK;,"New leader rings change at GSK: Maggie Urry meets Sir Chistopher Gent, whose
record, so far, includes masterminding the largest deal in British corporate
history", GSK; Lehman Brothers; Standard Life;,GSK Lehman Brothers Standard Life,2023-03-31 10:53:06.203297,No
6464,1024750,GSK.L,2005-04-29,2005-04-28, GSK;,GSK in speedy deal with FDA, US; GSK; Food and Drug Administration; FDA;,US GSK Food and Drug Administration FDA,2023-03-31 10:53:26.812418,Yes
6465,1025399,GSK.L,2005-05-04,2005-05-03, GSK;,Corixa purchase proposal boosts GSK PHARMACEUTICALS, US; GSK; UK; Merck;,US GSK UK Merck,2023-03-31 10:53:33.245670,No
6466,1028801,GSK.L,2005-05-25,2005-05-24, GSK;,"London Edition  1

AGM Briefing :Glaxosmithkline", Research Consultants; GSK; Association of British Insurers;,Research Consultants GSK Association of British Insurers,2023-03-31 10:53:39.598015,No
6467,1033199,GSK.L,2005-06-22,2005-06-21, GSK;,GSK unit in pioneering Aids vaccine venture PUBLIC-PRIVATE PARTNERSHIP:, International; GSK;,International GSK,2023-03-31 10:53:51.031669,Yes
6468,1041684,GSK.L,2005-08-23,2005-08-22, GSK;,"A tale of two treatments that are drawing growing interest Andrew Jack reports
on the antivirals Relenza and Tamiflu from GSK and Roche, which have so far had
very different commercial results", Roche; GSK; US; World Health Organisation;,Roche GSK US World Health Organisation,2023-03-31 10:53:57.428390,No
6469,1043513,GSK.L,2005-09-08,2005-09-07, GSK;,GSK in agreedCDollars 1.7bn bid for vaccine group, US; GSK; US for;,US GSK US for,2023-03-31 10:54:08.953600,Yes
6470,1045041,GSK.L,2005-09-16,2005-09-15, GSK;,UK: Boots could benefit from GSK's big pockets ALISON SMITH - LOMBARD, GSK; Boots Healthcare International; Boots Group; BHI;,GSK Boots Healthcare International Boots Group BHI,2023-03-31 10:54:20.929129,Yes
6471,1046627,GSK.L,2005-09-28,2005-09-27, GSK;,GSK focuses on four for chief, US; GSK;,US GSK,2023-03-31 10:54:32.603663,Yes
6472,1049945,GSK.L,2005-10-19,2005-10-18, GSK;,GSK rises on avian flu worries LONDON, World Health Organisation; GSK; US; Soco International; Tobacco; US Supreme Court; Imperial Tobacco;,World Health Organisation GSK US Soco International Tobacco US Supreme Court Imperial Tobacco,2023-03-31 10:54:39.051807,No
6473,1051741,GSK.L,2005-10-28,2005-10-27, GSK;,GSK AGREEMENT OFFERS NEW HOPE FOR SUFFERERS OF TUBERCULOSIS, Global TB Vaccine Foundation; GSK; TB;,Global TB Vaccine Foundation GSK TB,2023-03-31 10:54:45.480785,No
6474,1051773,GSK.L,2005-10-28,2005-10-27, Glaxo SmithKline;,GSK to offer discounts on pandemic flu drug, Group; Financial Times; Glaxo SmithKline;,Group Financial Times Glaxo SmithKline,2023-03-31 10:54:51.706981,No
6475,1052076,GSK.L,2005-11-01,2005-10-31, GSK;,GSK hopes to find malaria vaccine WORLD NEWS DIGEST:, Melinda; Gates Foundation; US; GSK;,Melinda Gates Foundation US GSK,2023-03-31 10:54:58.049474,No
6476,1055818,GSK.L,2005-11-22,2005-11-21, GSK;,GSK hit by asthma drug sales threat PHARMACEUTICALS, US Food and Drug Administration; GSK; FDA; US; Goldman Sachs; US bank;,US Food and Drug Administration GSK FDA US Goldman Sachs US bank,2023-03-31 10:55:09.982577,Yes
6477,1066848,GSK.L,2006-02-07,2006-02-06, GSK;,GSK research chief to run Gates project, Melinda; Gates Foundation; Gates; Microsoft; GSK; US National Cancer Institute;,Melinda Gates Foundation Gates Microsoft GSK US National Cancer Institute,2023-03-31 10:55:21.385691,Yes
6478,1067310,GSK.L,2006-02-09,2006-02-08, GSK;,"Core drugs boost GSK results *Net income up by 16 per cent at Pounds
6.7bn*Company clear for potential acquisitions*Seven products set for launch
this year", GSK; Pfizer; US; Morgan Stanley; US Food and Drug Administration; Merck; Gard-asil; US Federal Trade Commission; Glaxo;,GSK Pfizer US Morgan Stanley US Food and Drug Administration Merck Gard asil US Federal Trade Commission Glaxo,2023-03-31 10:55:28.180988,No
6479,1067316,GSK.L,2006-02-09,2006-02-08, GSK;,GSK's good news Alison Smith - Lombard, GSK; Boots Healthcare International;,GSK Boots Healthcare International,2023-03-31 10:55:39.727513,Yes
6480,1068008,GSK.L,2006-02-15,2006-02-14, GSK;,GSK pays Dollars 50mfor institute NEWS DIGEST, Pliva Research Institute; GSK;,Pliva Research Institute GSK,2023-03-31 10:55:46.048540,No
6481,1069985,GSK.L,2006-02-28,2006-02-27, GSK;,GSK receives approval for infant vaccine, UK; European Medicines Agency; GSK; Merck; Food and Drug Administration; US; Centres for Disease Control; FDA;,UK European Medicines Agency GSK Merck Food and Drug Administration US Centres for Disease Control FDA,2023-03-31 10:55:52.429617,No
6482,1070207,GSK.L,2006-03-01,2006-02-28, GSK;,GSK is criticised for army drug test, UK; US; Yale School of Medicine; Financial Times; GSK;,UK US Yale School of Medicine Financial Times GSK,2023-03-31 10:56:04.056169,Yes
6483,1075201,GSK.L,2006-03-31,2006-03-30, GSK;,GSK in effort to boost flu vaccine output, UK; GSK; New England Journal of Medicine;,UK GSK New England Journal of Medicine,2023-03-31 10:56:18.080553,Yes
6484,1078439,GSK.L,2006-04-24,2006-04-23, GSK;,GSK's venture capital funds steps up European focus, GSK; UK; European; US;,GSK UK European US,2023-03-31 10:56:24.556025,No
6485,1078888,GSK.L,2006-04-25,2006-04-24, GSK;,GSK fund increases its Europe focus, US; GSK; UK;,US GSK UK,2023-03-31 10:56:31.091023,No
6486,1080716,GSK.L,2006-05-09,2006-05-08, GSK;,"Animal rights extremists send threatening letter to individual  GSK investors
Sell your shares within 14 days or face public exposure, says message. Clive
CooksonandJohn Willmanreport", Huntingdon Life Sciences; GSK; London Stock Exchange; Oxford University; National Extremist Tactical Coordination Unit; Association; British Pharmaceutical Industry; Research Defence Society; Association of PrivateClient Investment Managers; UK Shareholders' Association; Companies House; Investment Management Association; Serious Organised Crimes Agency;,Huntingdon Life Sciences GSK London Stock Exchange Oxford University National Extremist Tactical Coordination Unit Association British Pharmaceutical Industry Research Defence Society Association of PrivateClient Investment Managers UK Shareholders Association Companies House Investment Management Association Serious Organised Crimes Agency,2023-03-31 10:56:37.804164,No
6487,1080770,GSK.L,2006-05-09,2006-05-08, GSK;,"GSK says investors targeted by extremists *Animal rights group in threat to
small shareholders", GSK; Huntingdon Life Sciences; National Extremist Tactical Co-ordination Unit; Oxford University; Companies House; Association; British Pharmaceutical Industry; Research Defence Society;,GSK Huntingdon Life Sciences National Extremist Tactical Co ordination Unit Oxford University Companies House Association British Pharmaceutical Industry Research Defence Society,2023-03-31 10:56:44.501265,No
6488,1080994,GSK.L,2006-05-10,2006-05-09, GSK;,GSK wins injunction against extremists, High Court; GSK; Institute of Chartered Secretaries; Department of Trade and Industry;,High Court GSK Institute of Chartered Secretaries Department of Trade and Industry,2023-03-31 10:56:50.854194,No
6489,1080995,GSK.L,2006-05-10,2006-05-09, GSK;,Extremists targeting GSK 'may lose e-mail accounts' ANIMAL RIGHTS ACTIVISTS, Huntingdon Life Sciences; GSK; National Extremism Tactical Co-ordination Unit; UK;,Huntingdon Life Sciences GSK National Extremism Tactical Co ordination Unit UK,2023-03-31 10:57:03.038948,Yes
6490,1082280,GSK.L,2006-05-18,2006-05-17, GSK;,Garnier to reign longer as GSK boss, US; GSK; Pfizer; Financial Times; Melinda Gates Foundation; AGM;,US GSK Pfizer Financial Times Melinda Gates Foundation AGM,2023-03-31 10:57:14.806026,Yes
6491,1082789,GSK.L,2006-05-22,2006-05-21, GSK;,Investors in GSK opting for anonymity, Huntingdon Life Sciences; House of Lords; GSK;,Huntingdon Life Sciences House of Lords GSK,2023-03-31 10:57:26.276295,Yes
6492,1084241,GSK.L,2006-05-31,2006-05-30, GSK;,Growing external role in GSK pipeline PHARMACEUTICALS, Melinda Gates Foundation; GSK; External Drug Discovery;,Melinda Gates Foundation GSK External Drug Discovery,2023-03-31 10:57:38.055240,Yes
6493,1084242,GSK.L,2006-05-31,2006-05-30, GSK;,"Unexpected radical created the blueprint for R&D Andrew Jack details the career
of the GSK executive who changed the way new drugs are created", SmithKline Beecham; GSK; Drug Discovery; Cambridge Antibody Technology; Lehman Brothers; US; SmithKline; Melinda Gates Foundation;,SmithKline Beecham GSK Drug Discovery Cambridge Antibody Technology Lehman Brothers US SmithKline Melinda Gates Foundation,2023-03-31 10:57:49.831169,Yes
6494,1084955,GSK.L,2006-06-06,2006-06-05, GSK;,Breast cancer drug trial lifts GSK, Morgan Stanley; GSK; US; American Society of Clinical Oncology; International Ludwig Institute for Cancer Research;,Morgan Stanley GSK US American Society of Clinical Oncology International Ludwig Institute for Cancer Research,2023-03-31 10:57:56.327541,No
6495,1092788,GSK.L,2006-07-27,2006-07-26, GSK;,GSK launches new vaccine for bird flu, GSK; Nomura Code;,GSK Nomura Code,2023-03-31 10:58:02.619610,No
6496,1096104,GSK.L,2006-08-25,2006-08-24, GSK;,GSK in Dollars 1.5bn licensing deal NEWS DIGEST, US; GSK; External Drug Discovery;,US GSK External Drug Discovery,2023-03-31 10:58:08.949337,No
6497,1097374,GSK.L,2006-09-06,2006-09-05, GSK;,"Britain's blackcurrant farmers win freedom from the Ribena  squeeze SOURCING:
GlaxoSmithKline is paying producers higher prices as it strives to maintain crop
supplies for its branded juice drink, says Fiona Harvey", UK; Common Agricultural Policy; GSK; Supermarkets;,UK Common Agricultural Policy GSK Supermarkets,2023-03-31 10:58:20.554853,Yes
6498,1098548,GSK.L,2006-09-12,2006-09-11, GSK;,GlaxoSmithKline in Dollars 3.1bn settlement of US tax dispute, US Internal Revenue Service; Glaxo; GSK; IRS; Glaxo Wellcome; US;,US Internal Revenue Service Glaxo GSK IRS Glaxo Wellcome US,2023-03-31 10:58:32.224161,Yes
6499,1099196,GSK.L,2006-09-18,2006-09-17, GSK;,GSK agrees breakthrough pricing deals, EU; European; GSK;,EU European GSK,2023-03-31 10:58:43.689744,Yes
6500,1100852,GSK.L,2006-09-28,2006-09-27, GSK;,"GSK wins partial victory in drive to curb 'parallel trading' in  drugs EUROPEAN
COURT OF FIRST INSTANCE", European Court; Commission; White &; GSK;,European Court Commission White GSK,2023-03-31 10:58:50.196306,No
6501,1100919,GSK.L,2006-09-28,2006-09-27, GSK;,"GSK wins 'parallel trade' battle *Ruling boosts drugs group's fight against
inter-European trading *Pharmaceuticals industry deemed 'special case' in EU
court", EU; European Court; Commission; GSK;,EU European Court Commission GSK,2023-03-31 10:59:03.358093,Yes
6502,1102487,GSK.L,2006-10-10,2006-10-09, GSK;,GSK buys CNS and gets anti-snore strip, US; CNS; GSK; Johnson; Pfizer; Boots International; GSK Consumer Healthcare; EU;,US CNS GSK Johnson Pfizer Boots International GSK Consumer Healthcare EU,2023-03-31 10:59:09.921006,No
6503,1105333,GSK.L,2006-10-26,2006-10-25, GSK;,GSK WILL GET UP TO 10% OF GARDASIL SALES, Merck; US; CSL; GSK;,Merck US CSL GSK,2023-03-31 10:59:16.176585,No
6504,1105334,GSK.L,2006-10-26,2006-10-25, GSK;,"Merck and GlaxoSmithKline are battling it out in the lucrative new world of
anti-cancer vaccinations Andrew Jack analyses how research in the 1990s has been
transformed into drugs with multi-billion dollar potential", UK; Merck; US; European Medicines Agency; US Food & Drug Administration; Joint Committee on Vaccinations; National Health Service; HPV; GSK; Morgan Stanley;,UK Merck US European Medicines Agency US Food Drug Administration Joint Committee on Vaccinations National Health Service HPV GSK Morgan Stanley,2023-03-31 10:59:22.479306,No
6505,1113451,GSK.L,2006-12-20,2006-12-19, GSK;,GSK to develop leukaemia drug PHARMACEUTICALS, Genentech; US; Morgan Stanley; GSK;,Genentech US Morgan Stanley GSK,2023-03-31 10:59:28.816784,No
6506,1119493,GSK.L,2007-02-05,2007-02-04, GSK;,Would be GSK chiefs halfway in the selection race PHARMACEUTICALS, US; GSK; Bristol-Myers Squibb;,US GSK Bristol Myers Squibb,2023-03-31 10:59:34.935789,No
6507,1120182,GSK.L,2007-02-09,2007-02-08, GSK;,GSK to form new disease research units PHARMACEUTICALS, GSK; US; US Food & Drug Administration;,GSK US US Food Drug Administration,2023-03-31 10:59:41.356820,No
6508,1127468,GSK.L,2007-03-28,2007-03-27, GSK;,NZ schoolgirls' vitamin C test on Ribena results in fine for GSK, NZDollars; Commerce Commission; GSK;,NZDollars Commerce Commission GSK,2023-03-31 10:59:47.432925,No
6509,1127779,GSK.L,2007-03-30,2007-03-29, GSK;,GSK partner accuses it of failures on flu drug PHARMACEUTICALS, GSK;,GSK,2023-03-31 10:59:56.728092,No
6510,1135581,GSK.L,2007-05-23,2007-05-22, GSK;,GSK faces further heart warning on diabetes drug, US; US Food & Drug Administration; FDA; New England Journal of Medicine; Merck; Prudential Equity Group; GSK; Deutsche Bank;,US US Food Drug Administration FDA New England Journal of Medicine Merck Prudential Equity Group GSK Deutsche Bank,2023-03-31 11:00:02.981580,No
6511,1135990,GSK.L,2007-05-24,2007-05-23, GSK;,GSK's Garnier says data will show Avandia safety, US; New England Journal of Medicine; Merck; NEJM; US Food and Drug Administration; Morgan Stanley; GSK; FDA;,US New England Journal of Medicine Merck NEJM US Food and Drug Administration Morgan Stanley GSK FDA,2023-03-31 11:00:09.307641,No
6512,1137386,GSK.L,2007-06-06,2007-06-05, GSK;,Fears over GSK diabetes drug, UK; New England Journal of Medicine; GSK; US; Avandia; Congress; Food and Drug Administration; FDA;,UK New England Journal of Medicine GSK US Avandia Congress Food and Drug Administration FDA,2023-03-31 11:00:18.794255,No
6513,1137822,GSK.L,2007-06-07,2007-06-06, GSK;,GSK chief accuses medical journal of 'mixing science with politics', Financial Times; Food and Drug Administration; US; NEJM; Merck; GSK;,Financial Times Food and Drug Administration US NEJM Merck GSK,2023-03-31 11:00:26.142039,No
6514,1138333,GSK.L,2007-06-12,2007-06-11, GSK;,GSK to launch obesity drug in US pharmacies, US; European Union-wide London-based; GSK; US Food and Drug Administration;,US European Union wide London based GSK US Food and Drug Administration,2023-03-31 11:00:32.396864,No
6515,1142665,GSK.L,2007-07-11,2007-07-10, GSK;,GSK adopts benevolent path for cancer drug, US; GSK; US National Cancer Institute;,US GSK US National Cancer Institute,2023-03-31 11:00:41.674878,No
6516,1144928,GSK.L,2007-07-26,2007-07-25, GSK;,GSK doubles buy-back pledge, Standard & Poors; US -; FDA; US; GSK;,Standard Poors US FDA US GSK,2023-03-31 11:00:50.904411,No
6517,1155699,GSK.L,2007-10-09,2007-10-08, GSK;,Job race challenges central to GSK vision, European Union; US; GSK; Merck; Egon Zehnder; Price Waterhouse; SmithKline Beecham;,European Union US GSK Merck Egon Zehnder Price Waterhouse SmithKline Beecham,2023-03-31 11:00:57.081423,No
6518,1155814,GSK.L,2007-10-09,2007-10-08, GSK;,GSK succession, GSK; Viehbacher;,GSK Viehbacher,2023-03-31 11:01:06.360329,No
6519,1155836,GSK.L,2007-10-09,2007-10-08, GSK;,Witty takes the helm at GSK, US; GSK;,US GSK,2023-03-31 11:01:15.740399,No
6520,1158999,GSK.L,2007-10-25,2007-10-24, GSK;,GSK slims down, US; GSK;,US GSK,2023-03-31 11:01:24.950614,No
6521,1163766,GSK.L,2007-11-15,2007-11-14, GSK;,US tells GSK to toughen risk warning on its diabetes drug, US; Food & Drug Administration; FDA; GSK; New England Journal of Medicine;,US Food Drug Administration FDA GSK New England Journal of Medicine,2023-03-31 11:01:31.066411,No
6522,1165170,GSK.L,2007-11-22,2007-11-21, GSK;,GSK buys Reliant in Dollars 1.65bn deal, Reliant Pharmaceuticals; GSK; US; ProNova;,Reliant Pharmaceuticals GSK US ProNova,2023-03-31 11:01:37.245161,No
6523,1165213,GSK.L,2007-11-22,2007-11-21, GSK;,GSK takes heart with Reliant, Reliant Pharmaceuticals; GSK; US; ProNova;,Reliant Pharmaceuticals GSK US ProNova,2023-03-31 11:01:43.285317,No
6524,1165272,GSK.L,2007-11-22,2007-11-21, GSK;,GSK buys US drug company in Dollars 1.65bn deal, Reliant Pharmaceuticals; GSK; US; Bear Stearns; ProNova;,Reliant Pharmaceuticals GSK US Bear Stearns ProNova,2023-03-31 11:01:49.367759,No
6525,1169196,GSK.L,2007-12-12,2007-12-11, GSK;,Shake-up at GSK aims to speed new medicines, GSK; Search;,GSK Search,2023-03-31 11:01:58.816978,No
6526,1169305,GSK.L,2007-12-12,2007-12-11, GSK;,GSK shake-up to speed up new drugs, GSK; Centres of Excellence for Drug Discovery;,GSK Centres of Excellence for Drug Discovery,2023-03-31 11:02:08.056896,No
6527,1169351,GSK.L,2007-12-12,2007-12-11, GSK;,Search for medicine to treat GSK's heart, Glaxo.; Harvard; Drug Discovery; GSK;,Glaxo Harvard Drug Discovery GSK,2023-03-31 11:02:17.237460,No
6528,1169395,GSK.L,2007-12-12,2007-12-11, GSK;,GSK's head of research works on a new formula, GSK; Harvard; Drug Discovery;,GSK Harvard Drug Discovery,2023-03-31 11:02:26.804181,No
6529,1169558,GSK.L,2007-12-13,2007-12-12, GSK;,GSK in Pounds 50m China neuro-research push, Financial Times; GSK; Drug Discovery;,Financial Times GSK Drug Discovery,2023-03-31 11:02:36.568353,No
6530,1169643,GSK.L,2007-12-13,2007-12-12, GSK;,GSK to spend Dollars 100m on R&D in China, Financial Times; GSK; Drug Discovery; HSBC;,Financial Times GSK Drug Discovery HSBC,2023-03-31 11:02:42.654013,No
6531,1176157,GSK.L,2008-01-24,2008-01-23, GSK;,GSK gets charity money for R&D, TB Alliance; Melinda Gates Foundation; GSK.; GSK; Pliva Institute;,TB Alliance Melinda Gates Foundation GSK GSK Pliva Institute,2023-03-31 11:02:51.969156,No
6532,1176815,GSK.L,2008-01-25,2008-01-24, GSK;,More limits on GSK's Avandia, European Medicines Agency; EMEA; US Food & Drug Administration; US; UBS; FDA; New England Journal of Medicine; GSK;,European Medicines Agency EMEA US Food Drug Administration US UBS FDA New England Journal of Medicine GSK,2023-03-31 11:03:01.311948,No
6533,1178749,GSK.L,2008-02-04,2008-02-03, GSK;,GSK's US vaccine launch in doubt, US; US Food & Drug Administration; GSK; FDA; Merck; Citibank;,US US Food Drug Administration GSK FDA Merck Citibank,2023-03-31 11:03:10.809525,No
6534,1179408,GSK.L,2008-02-07,2008-02-06, GSK;,Sanofi dismisses GSK cancer vaccine as inferior, Merck; US; GSK; UK; Food and Drug Administration; Euros;,Merck US GSK UK Food and Drug Administration Euros,2023-03-31 11:03:17.051145,No
6535,1179722,GSK.L,2008-02-08,2008-02-07, GSK;,GSK chief-in-waiting promises to diversify as shares tumble, UK; GSK; UBS;,UK GSK UBS,2023-03-31 11:03:23.288707,No
6536,1179733,GSK.L,2008-02-08,2008-02-07, GSK;,GSK vows to diversify as shares tumble, UK; GSK; UBS;,UK GSK UBS,2023-03-31 11:03:29.329748,No
6537,1187163,GSK.L,2008-03-17,2008-03-16, GSK;,GSK varies prices to raise sales, GSK;,GSK,2023-03-31 11:03:38.572193,No
6538,1193717,GSK.L,2008-04-24,2008-04-23, GSK;,GSK hit by generics and slump in sales, US -; GSK; US Food & Drug Administration; US; Morgan Stanley; UCB; FDA;,US GSK US Food Drug Administration US Morgan Stanley UCB FDA,2023-03-31 11:03:47.819570,No
6539,1193935,GSK.L,2008-04-25,2008-04-24, GSK;,JP to GSK: get therapy, Harvard Business Review; GSK;,Harvard Business Review GSK,2023-03-31 11:03:57.057749,No
6540,1198129,GSK.L,2008-05-19,2008-05-18, GSK;,GSK chief leaves a mixed prognosis, Glaxo Wellcome; SmithKline Beecham; GSK;,Glaxo Wellcome SmithKline Beecham GSK,2023-03-31 11:04:03.147902,No
6541,1197881,GSK.L,2008-05-20,2008-05-19, GSK;,GSK vaccine for flu pandemic wins approval, European Medicines Agency; GSK; US; World Health Organisation;,European Medicines Agency GSK US World Health Organisation,2023-03-31 11:04:12.479649,No
6542,1199232,GSK.L,2008-05-28,2008-05-27, GSK;,GSK dealt twin blow by brokers, Morgan Stanley; US; GSK; Merck; US Food and Drug Administration; UK;,Morgan Stanley US GSK Merck US Food and Drug Administration UK,2023-03-31 11:04:21.801545,No
6543,1201424,GSK.L,2008-06-10,2008-06-09, GSK;,GSK to shake-up research strategies, GSK;,GSK,2023-03-31 11:04:30.991133,No
6544,1202088,GSK.L,2008-06-13,2008-06-12, GSK;,GSK chief pushes for expansion into new markets, GSK; Financial Times;,GSK Financial Times,2023-03-31 11:04:40.798462,No
6545,1202136,GSK.L,2008-06-13,2008-06-12, GSK;,New GSK boss says will try to cut 'nasty surprises', GSK; Financial Times; US Food & Drug Administration;,GSK Financial Times US Food Drug Administration,2023-03-31 11:04:50.074170,No
6546,1205003,GSK.L,2008-07-01,2008-06-30, GSK;,GSK faces US delay on cancer vaccine, FDA; US; Food & Drug Administration; Merck; GSK;,FDA US Food Drug Administration Merck GSK,2023-03-31 11:04:56.137880,No
6547,1205068,GSK.L,2008-07-01,2008-06-30, GSK;,GSK's US vaccine approval put back, Cervarix  Group; US; Food & Drug Administration; Merck; FDA; GSK;,Cervarix Group US Food Drug Administration Merck FDA GSK,2023-03-31 11:05:02.227031,No
6548,1206224,GSK.L,2008-07-08,2008-07-07, GSK;,Blow for GSK's breast cancer drug, National Health Service; National Institute of Health and Clinical Excellence; GSK; Department of Health; US;,National Health Service National Institute of Health and Clinical Excellence GSK Department of Health US,2023-03-31 11:05:11.565287,No
6549,1206770,GSK.L,2008-07-11,2008-07-10, GSK;,GSK executive forced to quit Ofsted, GSK;,GSK,2023-03-31 11:05:20.805994,No
6550,1208643,GSK.L,2008-07-22,2008-07-21, GSK;,GSK in A$20m Relenza settlement, GSK; Biota; National Health Service; US; Roche;,GSK Biota National Health Service US Roche,2023-03-31 11:05:30.057330,No
6551,1208824,GSK.L,2008-07-24,2008-07-23, GSK;,Witty unveils three-fold approach for GSK, GSK;,GSK,2023-03-31 11:05:39.281927,No
6552,1210515,GSK.L,2008-08-04,2008-08-03, GSK;,GSK seeks fixed-price deal with NHS, Department of Health; National Health Service; US; National Institute for Health and Clinical Excellence; NHS; Merck; GSK; UK;,Department of Health National Health Service US National Institute for Health and Clinical Excellence NHS Merck GSK UK,2023-03-31 11:05:45.529969,No
6553,1215205,GSK.L,2008-09-09,2008-09-08, GSK;,GSK executive quits to lead rival, North American Pharmaceuticals; GSK; US; American Depository; Goldman Sachs; Pfizer;,North American Pharmaceuticals GSK US American Depository Goldman Sachs Pfizer,2023-03-31 11:05:54.836976,No
6554,1219570,GSK.L,2008-10-02,2008-10-01, GSK;,GSK in talks over research job cuts, US; GSK;,US GSK,2023-03-31 11:06:04.144586,No
6555,1219619,GSK.L,2008-10-02,2008-10-01, GSK;,GSK starts redundancy talks with global R&D workers, US; GSK;,US GSK,2023-03-31 11:06:13.397006,No
6556,1223260,GSK.L,2008-10-22,2008-10-21, GSK;,GSK pays$170m for oral product, US; UK; GSK Consumer Healthcare; GSK;,US UK GSK Consumer Healthcare GSK,2023-03-31 11:06:19.464567,No
6557,1234024,GSK.L,2008-12-23,2008-12-22, GSK;,GSK halts donations to political parties, US; Financial Times; GSK;,US Financial Times GSK,2023-03-31 11:06:28.739411,No
6558,1239854,GSK.L,2009-02-03,2009-02-02, GSK;,News Corp's heir apparent to join GSK board, UK; News Corporation Europe; GSK; British Sky Broadcasting; News Corp owns; 39.1 per; News Corp's; Financial Times;,UK News Corporation Europe GSK British Sky Broadcasting News Corp owns per News Corp s Financial Times,2023-03-31 11:06:38.116758,No
6559,1239855,GSK.L,2009-02-03,2009-02-02, GSK;,James Murdoch joins GSK board, News Corporation Europe; GSK; British Sky Broadcasting; Financial Times;,News Corporation Europe GSK British Sky Broadcasting Financial Times,2023-03-31 11:06:47.389478,No
6560,1240342,GSK.L,2009-02-06,2009-02-05, GSK;,GSK raises provisions in extension of group revamp, GSK; Pfizer;,GSK Pfizer,2023-03-31 11:06:56.638824,No
6561,1244766,GSK.L,2009-03-05,2009-03-04, GSK;,GSK takes lead on performance pay, GSK; US;,GSK US,2023-03-31 11:07:05.849133,No
6562,1244989,GSK.L,2009-03-06,2009-03-05, GSK;,GSK suffers cancer drug blow, National Health Service; National Institute for Health and Clinical Excellence; GSK;,National Health Service National Institute for Health and Clinical Excellence GSK,2023-03-31 11:07:11.959833,No
6563,1251179,GSK.L,2009-04-17,2009-04-16, GSK;,GSK and Pfizer pool resources for new strategy on HIV drugs, Pfizer; US; UBS; GSK;,Pfizer US UBS GSK,2023-03-31 11:07:21.175563,No
6564,1251960,GSK.L,2009-04-21,2009-04-20, GSK;,GSK expands in skincare with Stiefel, Stiefel Laboratories; US; GSK; Pfizer;,Stiefel Laboratories US GSK Pfizer,2023-03-31 11:07:30.395398,No
6565,1252004,GSK.L,2009-04-21,2009-04-20, GSK;,GSK in $3.6bn deal for Stiefel, US; Stiefel Laboratories; GSK; Pfizer;,US Stiefel Laboratories GSK Pfizer,2023-03-31 11:07:39.624540,No
6566,1252512,GSK.L,2009-04-23,2009-04-22, GSK;,GSK earnings fall 28% on US decline, GSK; US; European Union;,GSK US European Union,2023-03-31 11:07:48.905865,No
6567,1255591,GSK.L,2009-05-13,2009-05-12, GSK;,GSK takes 16% stake in Aspen, GSK; Bristol-Myers Squibb; UCB;,GSK Bristol Myers Squibb UCB,2023-03-31 11:07:58.131781,No
6568,1256590,GSK.L,2009-05-20,2009-05-19, GSK;,Charity to bridge GSK R&D gap," Cancer Research Technology; Cancer Research UK,; GSK; Cancer Research;",Cancer Research Technology Cancer Research UK GSK Cancer Research,2023-03-31 11:08:07.398969,No
6569,1259861,GSK.L,2009-06-10,2009-06-09, GSK;,GSK/Shenzhen, GSK; UBS;,GSK UBS,2023-03-31 11:08:16.661867,No
6570,1260056,GSK.L,2009-06-12,2009-06-11, GSK;,GSK to cut pricesof medicines in emerging markets, UK; Financial Times; GSK;,UK Financial Times GSK,2023-03-31 11:08:25.871101,No
6571,1260586,GSK.L,2009-06-16,2009-06-15, GSK;,GSK in generic drug alliance, US; Matrix Corp; Glaxo; GSK; Pfizer;,US Matrix Corp Glaxo GSK Pfizer,2023-03-31 11:08:35.088017,No
6572,1265857,GSK.L,2009-07-23,2009-07-22, GSK;,Dose of joy for GSK, GSK; US;,GSK US,2023-03-31 11:08:44.297183,No
6573,1265924,GSK.L,2009-07-23,2009-07-22, GSK;,GSK's swine flu arsenal grows, GSK;,GSK,2023-03-31 11:08:53.520175,No
6574,1265941,GSK.L,2009-07-23,2009-07-22, GSK;,GSK bolsters its swine flu arsenal with masks and diagnostics deal, GSK; Pfizer; Eli Lilly;,GSK Pfizer Eli Lilly,2023-03-31 11:08:59.541103,No
6575,1265947,GSK.L,2009-07-23,2009-07-22, GSK;,Generic drugmakers depress sales at GSK, US; US -; Food and Drug Administration; GSK;,US US Food and Drug Administration GSK,2023-03-31 11:09:05.590174,No
6576,1266771,GSK.L,2009-07-28,2009-07-27, GSK;,GSK link marks shift for Amgen, US; UK; GSK; European Union; Financial Times; US Internal Revenue Service;,US UK GSK European Union Financial Times US Internal Revenue Service,2023-03-31 11:09:11.664901,No
6577,1266774,GSK.L,2009-07-28,2009-07-27, GSK;,Amgen in deal with GSK to market osteoporosis drug, US; UK; GSK; European Union; Financial Times; US Internal Revenue Service;,US UK GSK European Union Financial Times US Internal Revenue Service,2023-03-31 11:09:17.764237,No
6578,1275959,GSK.L,2009-10-07,2009-10-06, GSK;,GSK eyes 2bn flu vaccine sales, US; GSK; European Union; US Food and Drug Administration; World Health Organisation;,US GSK European Union US Food and Drug Administration World Health Organisation,2023-03-31 11:09:27.062616,No
6579,1276931,GSK.L,2009-10-15,2009-10-14, GSK;,GSK among the winners as Footsie reaches 2009 peak, US; GSK; UBS; Goldman Sachs; Royal Bank; Group; Morgan Stanley; Vedanta Resources; BP; BG Group; International Power;,US GSK UBS Goldman Sachs Royal Bank Group Morgan Stanley Vedanta Resources BP BG Group International Power,2023-03-31 11:09:36.471237,No
6580,1277650,GSK.L,2009-10-20,2009-10-19, GSK;,GSK faces Merck in vaccine price war, Merck; US; US vice-president; Food and Drug Administration; European Union; HPV; US Centers for Disease Control and Protection; GSK;,Merck US US vice president Food and Drug Administration European Union HPV US Centers for Disease Control and Protection GSK,2023-03-31 11:09:45.977874,No
6581,1279155,GSK.L,2009-10-29,2009-10-28, GSK;,GSK takes step along desired path of evolution, US; Bernstein Research; GSK; Stiefel Laboratories; Pfizer;,US Bernstein Research GSK Stiefel Laboratories Pfizer,2023-03-31 11:09:55.245163,No
6582,1280035,GSK.L,2009-11-03,2009-11-02, GSK;,Shire hires GSK contender, GSK; US; Smith Kline Beecham;,GSK US Smith Kline Beecham,2023-03-31 11:10:01.327250,No
6583,1282085,GSK.L,2009-11-17,2009-11-16, GSK;,Vaccine for smokers draws closer as GSK agrees US biotech deal, US; Nabi Pharmaceuticals; GSK; American Lung Association; Pfizer;,US Nabi Pharmaceuticals GSK American Lung Association Pfizer,2023-03-31 11:10:10.619832,No
6584,1284063,GSK.L,2009-11-30,2009-11-29, GSK;,GSK to slash drug prices for developing countries, UBS; Bayer; GSK; US;,UBS Bayer GSK US,2023-03-31 11:10:19.859654,No
6585,1286072,GSK.L,2009-12-15,2009-12-14, GSK;,GSK's$15m fees data go online, US; GSK; Hospital; Eli Lilly; Merck;,US GSK Hospital Eli Lilly Merck,2023-03-31 11:10:29.059593,No
6586,1290208,GSK.L,2010-01-21,2010-01-20, GSK;,GSK gives price pledge on experimental malaria vaccine, Council on Foreign Relations; GSK; Melinda; Gates Foundation;,Council on Foreign Relations GSK Melinda Gates Foundation,2023-03-31 11:10:38.320304,No
6587,1291951,GSK.L,2010-02-01,2010-01-31, GSK;,"GSK set to axe 3,000 jobs in shift from drugs", GSK; Pfizer;,GSK Pfizer,2023-03-31 11:10:47.756118,No
6588,1292605,GSK.L,2010-02-05,2010-02-04, GSK;,GSK in symbolic shift away from antidepressants, 500m; GSK; UK; Pfizer; Imperial College;,m GSK UK Pfizer Imperial College,2023-03-31 11:10:53.751156,No
6589,1295155,GSK.L,2010-02-23,2010-02-22, GSK;,Renewed calls to withdraw GSK drug drag Footsie lower, US Senate; US; GSK; Royal Bank; Lloyds Banking Group; Merrill Lynch; Merrill; Credit Suisse; LSE; VT Group; 126p-a-share;,US Senate US GSK Royal Bank Lloyds Banking Group Merrill Lynch Merrill Credit Suisse LSE VT Group p a share,2023-03-31 11:11:03.077274,No
6590,1299851,GSK.L,2010-03-29,2010-03-28, GSK;,GSK looks to Japan for partnerships, GSK;,GSK,2023-03-31 11:11:12.267062,No
6591,1302781,GSK.L,2010-04-20,2010-04-19, GSK;,FDA steps up GSK drug scrutiny, Senate; Food and Drug Administration; GSK; TIDE; FDA; Institute of Medicine; US; US Senator Chuck; Morgan Stanley; US Avandia;,Senate Food and Drug Administration GSK TIDE FDA Institute of Medicine US US Senator Chuck Morgan Stanley US Avandia,2023-03-31 11:11:18.423310,No
6592,1303674,GSK.L,2010-04-29,2010-04-28, GSK;,GSK relies more on emerging markets, US; GSK; Pfizer; UBS;,US GSK Pfizer UBS,2023-03-31 11:11:27.575911,No
6593,1304706,GSK.L,2010-05-06,2010-05-05, GSK;,Corrections: GSK; Charlie Melancon; Jon Moulton, GSK; Congress; Better Capital;,GSK Congress Better Capital,2023-03-31 11:11:33.581314,No
6594,1304760,GSK.L,2010-05-06,2010-05-05, GSK;,Corrections: GSK; Charlie Melancon; Nomura, GSK; Congress; Nomura;,GSK Congress Nomura,2023-03-31 11:11:39.548337,No
6595,1305382,GSK.L,2010-05-12,2010-05-11, GSK;,GSK braced to pay up to $1bn in diabetes drug settlement, GSK; US; Senate;,GSK US Senate,2023-03-31 11:11:48.737560,No
6596,1313581,GSK.L,2010-07-13,2010-07-12, GSK;,FDA puts GSK drug under the microscope, US; Food and Drug Administration; GSK; FDA; Morgan Stanley;,US Food and Drug Administration GSK FDA Morgan Stanley,2023-03-31 11:11:57.931779,No
6597,1320024,GSK.L,2010-09-07,2010-09-06, GSK;,GSK/Avandia, UK; British Medical Journal; US's Food and Drug Administration; US; GSK;,UK British Medical Journal US s Food and Drug Administration US GSK,2023-03-31 11:12:07.282083,No
6598,1320562,GSK.L,2010-09-09,2010-09-08, GSK;,Goldman's M&A dealmaker Dingemans set to join GSK, Goldman Sachs; GSK; UK; ViiV Healthcare; CFO; Financial Times; GE; Goldman; BAA;,Goldman Sachs GSK UK ViiV Healthcare CFO Financial Times GE Goldman BAA,2023-03-31 11:12:13.402263,No
6599,1322428,GSK.L,2010-09-24,2010-09-23, GSK;,GSK hit by twin blows on Avandia, US; European Medicines Agency; US Food and Drug Administration; FDA; GSK;,US European Medicines Agency US Food and Drug Administration FDA GSK,2023-03-31 11:12:22.643179,No
6600,1323801,GSK.L,2010-10-05,2010-10-04, GSK;,GSK spins out standalone pain relief company, GSK; Eli Lilly; US; Thomson; Reuters; Bernstein Research;,GSK Eli Lilly US Thomson Reuters Bernstein Research,2023-03-31 11:12:31.941286,No
6601,1326178,GSK.L,2010-10-22,2010-10-21, GSK;,GSK is hurt by Avandia problems, US; UK; GSK;,US UK GSK,2023-03-31 11:12:41.124298,No
6602,1330563,GSK.L,2010-11-19,2010-11-18, GSK;,GSK to discount price of vaccine in Africa, GSK; Global Alliance; MSF;,GSK Global Alliance MSF,2023-03-31 11:12:50.347023,No
6603,1337362,GSK.L,2011-01-19,2011-01-18, GlaxoSmithKline;,GSK charge underlines regulatory fears, US; Public Citizen; Pfizer; Merck; Internal Revenue Service;,US Public Citizen Pfizer Merck Internal Revenue Service,2023-03-31 11:12:59.606620,No
6604,1339444,GSK.L,2011-02-03,2011-02-02, GSK;,GSK raises $1.7bn via Quest Diagnostics exit, US; Pfizer; GSK;,US Pfizer GSK,2023-03-31 11:13:08.768671,No
6605,1339548,GSK.L,2011-02-04,2011-02-03, GSK;,GSK reverses freeze on buy-backs, Merck; Pfizer; GSK; Glaxo; Evolution Securities;,Merck Pfizer GSK Glaxo Evolution Securities,2023-03-31 11:13:14.811205,No
6606,1339579,GSK.L,2011-02-04,2011-02-03, GSK;,GSK set to launch 2bn share buy-back, Merck; Pfizer; GSK; US;,Merck Pfizer GSK US,2023-03-31 11:13:20.794210,No
6607,1341022,GSK.L,2011-02-14,2011-02-13, GSK;,GSK looks to academia for new drugs, GSK; Royal Free and University College Medical School;,GSK Royal Free and University College Medical School,2023-03-31 11:13:30.054882,No
6608,1355809,GSK.L,2011-06-09,2011-06-08, GSK;,GlaxoSmithKline, European Union - GSK; GSK; US;,European Union GSK GSK US,2023-03-31 11:13:39.229235,No
6609,1360240,GSK.L,2011-07-14,2011-07-13, GSK;,GSK left behind as miners lead the way, US; GSK; Randgold Resources; Goldman Sachs; BAE Systems; XX Small;,US GSK Randgold Resources Goldman Sachs BAE Systems XX Small,2023-03-31 11:13:45.272824,No
6610,1360273,GSK.L,2011-07-14,2011-07-13, GSK;,GSK misses out on rally after US sales of asthma drug slump, US; US Food and Drug Administration; Goldman Sachs; GSK; BAE Systems; British Foods; Pursuit Dynamics; XX Small;,US US Food and Drug Administration Goldman Sachs GSK BAE Systems British Foods Pursuit Dynamics XX Small,2023-03-31 11:13:51.536398,No
6611,1361814,GSK.L,2011-07-27,2011-07-26, GlaxoSmithKline;,Buoyant GSK vows to boost efficiency, GlaxoSmithKline; UK;,GlaxoSmithKline UK,2023-03-31 11:14:00.778118,No
6612,1365825,GSK.L,2011-09-02,2011-09-01, GSK;,GSK sale of non-core assets advances, US; Bayer; Goldman Sachs; GSK;,US Bayer Goldman Sachs GSK,2023-03-31 11:14:10.034806,No
6613,1366284,GSK.L,2011-09-05,2011-09-04, GSK;,Top GSK scientist inpush on Alzheimer's, US; Pfizer; GSK; US National Institutes of Health;,US Pfizer GSK US National Institutes of Health,2023-03-31 11:14:19.251520,No
6614,1372694,GSK.L,2011-10-27,2011-10-26, GSK;,GlaxoSmithKline, UK; US; GSK;,UK US GSK,2023-03-31 11:14:28.459936,No
6615,1372723,GSK.L,2011-10-27,2011-10-26, GSK;,GSK puts 700m tag on brands for disposal, Advisers; UK; GSK; US;,Advisers UK GSK US,2023-03-31 11:14:37.668710,No
6616,1373532,GSK.L,2011-10-31,2011-10-30, GSK;,Sanofi and GSK sued over birth defect drug, SmithKline; US; Food and Drug Administration; SKF; GSK;,SmithKline US Food and Drug Administration SKF GSK,2023-03-31 11:14:43.748820,No
6617,1378814,GSK.L,2011-12-12,2011-12-11, GlaxoSmithKline;,GSK outlines drive to boost earnings, Goldman Sachs; Financial Times; UK; Pfizer;,Goldman Sachs Financial Times UK Pfizer,2023-03-31 11:14:49.781174,No
6618,1379092,GSK.L,2011-12-13,2011-12-12, GSK;,GSK unit faces SEC fraud case, US Securities and Exchange Commission; SEC; Stiefel Laboratories; GSK; Stiefel Labs; Round Table Healthcare Partners;,US Securities and Exchange Commission SEC Stiefel Laboratories GSK Stiefel Labs Round Table Healthcare Partners,2023-03-31 11:14:59.128811,No
6619,1379121,GSK.L,2011-12-13,2011-12-12, GSK;,SEC charges GSK arm with fraud, Securities and Exchange Commission; Stiefel Laboratories; GSK; SEC;,Securities and Exchange Commission Stiefel Laboratories GSK SEC,2023-03-31 11:15:08.440073,No
6620,1381662,GSK.L,2012-01-10,2012-01-09, GSK;,GlaxoSmithKline, Barclays Capital; US; GSK;,Barclays Capital US GSK,2023-03-31 11:15:17.653313,No
6621,1384880,GSK.L,2012-02-08,2012-02-07, GSK;,GlaxoSmithKline, UK; GSK; Goldman Sachs; Glaxo;,UK GSK Goldman Sachs Glaxo,2023-03-31 11:15:26.824550,No
6622,1384881,GSK.L,2012-02-08,2012-02-07, GSK;,GSK cuts Europe risk with daily cash 'sweep' from fragile nations, European Central Bank; GSK; Bernstein Research;,European Central Bank GSK Bernstein Research,2023-03-31 11:15:36.081438,No
6623,1393728,GSK.L,2012-04-20,2012-04-19, GSK;,GSK falters in $2.6bn move on US biotech, Human; Genome Sciences; US; HGS; FDA; UK; Olivetree Securities; GSK; HGSI; Deutsche Bank; Goldman Sachs and Credit Suisse;,Human Genome Sciences US HGS FDA UK Olivetree Securities GSK HGSI Deutsche Bank Goldman Sachs and Credit Suisse,2023-03-31 11:15:42.234719,No
6624,1393746,GSK.L,2012-04-20,2012-04-19, GSK;,GSK/Human Genome, US; Human; Genome Sciences; Swiss; GSK;,US Human Genome Sciences Swiss GSK,2023-03-31 11:15:51.409872,No
6625,1394227,GSK.L,2012-04-26,2012-04-25, GSK;,GSK to buy back 2.5bn in shares, Human Genome Sciences; GSK;,Human Genome Sciences GSK,2023-03-31 11:16:00.676703,No
6626,1396037,GSK.L,2012-05-10,2012-05-09, GSK;,GSK turns hostile with $2.6bn bid for HGS, Human Genome Sciences; US; HGS; UK; National Health Service; GSK;,Human Genome Sciences US HGS UK National Health Service GSK,2023-03-31 11:16:06.987148,No
6627,1397069,GSK.L,2012-05-18,2012-05-17, GSK;,HGSI fights GSK bid with 'poison pill', Human Genome Sciences; GSK; HGSI; Credit Suisse alongside Goldman Sachs; Goldman Sachs; US; THS Partners;,Human Genome Sciences GSK HGSI Credit Suisse alongside Goldman Sachs Goldman Sachs US THS Partners,2023-03-31 11:16:16.321278,No
6628,1398494,GSK.L,2012-05-30,2012-05-29, GSK;,Human Genome Sciences sued over GSK 'poison pill', Human Genome Sciences; US; HGSI; GSK;,Human Genome Sciences US HGSI GSK,2023-03-31 11:16:25.809679,No
6629,1398311,GSK.L,2012-05-31,2012-05-30, GSK;,GSK in push to replace takeover target's board, Human Genome Sciences; US; HGS; GSK;,Human Genome Sciences US HGS GSK,2023-03-31 11:16:34.987988,No
6630,1402259,GSK.L,2012-07-03,2012-07-02, GSK;,"GSK pays $3bn to settle charges over 'happy, horny, skinny pill'", US; US Department of Justice; GSK; US Food and Drug Administration; Pfizer; Harvard Medical School;,US US Department of Justice GSK US Food and Drug Administration Pfizer Harvard Medical School,2023-03-31 11:16:41.130322,No
6631,1402461,GSK.L,2012-07-04,2012-07-03, GSK;,GlaxoSmithKline, Barclays; US; Eli Lilly; GSK;,Barclays US Eli Lilly GSK,2023-03-31 11:16:50.364351,No
6632,1403928,GSK.L,2012-07-17,2012-07-16, GSK;,GlaxoSmithKline agrees $3bn takeover of US biotech HGS, Human Genome Sciences; US; GSK; HGS; Morgan Stanley; Goldman Sachs and Credit Suisse;,Human Genome Sciences US GSK HGS Morgan Stanley Goldman Sachs and Credit Suisse,2023-03-31 11:16:59.786682,No
6633,1403947,GSK.L,2012-07-17,2012-07-16, GSK;,GSK/Human Genome, Human Genome Sciences; HSG; HGS; GSK;,Human Genome Sciences HSG HGS GSK,2023-03-31 11:17:08.977808,No
6634,1404921,GSK.L,2012-07-26,2012-07-25, GSK;,GlaxoSmithKline, US; GSK; Human Genome Sciences; Merck;,US GSK Human Genome Sciences Merck,2023-03-31 11:17:18.168811,No
6635,1407363,GSK.L,2012-08-23,2012-08-22, GSK;,Downgrade is bitter medicine for GlaxoSmithKline investors, GSK; Deutsche Bank; Africa Oil; Carlyle Group; CPP Group; Man Group; 144p; MWB;,GSK Deutsche Bank Africa Oil Carlyle Group CPP Group Man Group p MWB,2023-03-31 11:17:24.264507,No
6636,1418796,GSK.L,2012-11-27,2012-11-26, GSK;,GSK raises India and Nigeria holdings, GlaxoSmithKline Consumer Healthcare; GSK;,GlaxoSmithKline Consumer Healthcare GSK,2023-03-31 11:17:33.460689,No
6637,1426103,GSK.L,2013-02-06,2013-02-05, GSK;,GSK agrees to release more drug trials data, US; GSK; US Food and Drug Administration; Association; British Pharmaceutical Industry;,US GSK US Food and Drug Administration Association British Pharmaceutical Industry,2023-03-31 11:17:42.831963,No
6638,1443551,GSK.L,2013-07-12,2013-07-11, GSK;,China accuses GSK of bribery, Ministry of Public Security; GSK; UK Foreign Office;,Ministry of Public Security GSK UK Foreign Office,2023-03-31 11:17:52.045166,No
6639,1443931,GSK.L,2013-07-16,2013-07-15, GSK;,China steps up GSK bribery probe, GSK; Ministry of Public Security;,GSK Ministry of Public Security,2023-03-31 11:18:01.184186,No
6640,1443954,GSK.L,2013-07-16,2013-07-15, GSK;,GSK case shows peril of operating in corrupt markets, Ministry of Public Security; GSK; US;,Ministry of Public Security GSK US,2023-03-31 11:18:10.354134,No
6641,1444034,GSK.L,2013-07-18,2013-07-17, GSK;,GSK steps up probe into China scandal, EY; GSK; US; Department;,EY GSK US Department,2023-03-31 11:18:16.316100,No
6642,1444065,GSK.L,2013-07-18,2013-07-17, GSK;,GSK dispatches top auditors to investigate China scandal, EY; GSK; US;,EY GSK US,2023-03-31 11:18:22.270816,No
6643,1444696,GSK.L,2013-07-22,2013-07-21, GSK;,GSK chief to face bribery probe quiz, UK; US; GSK;,UK US GSK,2023-03-31 11:18:31.430154,No
6644,1444703,GSK.L,2013-07-25,2013-07-24, GSK;,GSK probe intensifies calls over China crime pact, GSK; US; UK Serious Fraud Office; US Department of Justice; Financial Times; US Securities and Exchange Commission;,GSK US UK Serious Fraud Office US Department of Justice Financial Times US Securities and Exchange Commission,2023-03-31 11:18:40.804642,No
6645,1444776,GSK.L,2013-07-25,2013-07-24, GSK;,GlaxoSmithKline, GSK;,GSK,2023-03-31 11:18:49.922696,No
6646,1444942,GSK.L,2013-07-26,2013-07-25, GSK;,GSK replaces China head amid bribe probe, GSK; Hong-Kong; Financial Times; US;,GSK Hong Kong Financial Times US,2023-03-31 11:18:59.148276,No
6647,1445404,GSK.L,2013-07-31,2013-07-30, GSK;,Former GSK China chief to return to face questions, UK; GSK; China;,UK GSK China,2023-03-31 11:19:08.302970,No
6648,1453939,GSK.L,2013-10-24,2013-10-23, GSK;,GlaxoSmithKline, GSK; Bristol-Myers Squibb; US;,GSK Bristol Myers Squibb US,2023-03-31 11:19:17.527057,No
6649,1458339,GSK.L,2013-12-04,2013-12-03, GSK;,Cameron defends GSK's reputation, GSK; GSK.; Financial Times; US; Mr Humphrey;,GSK GSK Financial Times US Mr Humphrey,2023-03-31 11:19:26.721654,No
6650,1460074,GSK.L,2013-12-17,2013-12-16, GSK;,GSK in India, GSK Consumer Healthcare; GSK; GSK Pharma;,GSK Consumer Healthcare GSK GSK Pharma,2023-03-31 11:19:35.896369,No
6651,1460117,GSK.L,2013-12-17,2013-12-16, GSK;,Shake-up of sales practices at GSK, US; GSK; Health Action International;,US GSK Health Action International,2023-03-31 11:19:45.134397,No
6652,1460046,GSK.L,2013-12-18,2013-12-17, GSK;,GSK China probe flags up wider worries," GSK; US; Eli Lilly; EU Chamber of Commerce; Financial; 60-80; US ""; Public Citizen;",GSK US Eli Lilly EU Chamber of Commerce Financial US Public Citizen,2023-03-31 11:19:51.162791,No
6653,1464167,GSK.L,2014-02-06,2014-02-05, GSK;,Cash and a strong pipeline give GSK a shot in the arm, GSK; AZ;,GSK AZ,2023-03-31 11:20:00.280169,No
6654,1470637,GSK.L,2014-04-08,2014-04-07, GSK;,Reform of pharma practices should go wider than GSK, GSK;,GSK,2023-03-31 11:20:09.434059,No
6655,1474173,GSK.L,2014-05-15,2014-05-14, GSK;,GSK's chopsocky shocks pose questions over UK's ethics, Pfizer; GSK; Operation Headless Chicken; US Department of Justice;,Pfizer GSK Operation Headless Chicken US Department of Justice,2023-03-31 11:20:15.528228,No
6656,1474227,GSK.L,2014-05-15,2014-05-14, GSK;,GSK in China, GSK; Pfizer; Johnson; Merck;,GSK Pfizer Johnson Merck,2023-03-31 11:20:24.822312,No
6657,1475260,GSK.L,2014-05-28,2014-05-27, GSK;,SFO launches probe into GSK, UK; SFO; GSK; US Department of Justice; US;,UK SFO GSK US Department of Justice US,2023-03-31 11:20:34.077761,No
6658,1475449,GSK.L,2014-05-29,2014-05-28, GSK;,GSK salesmen press for company to reimburse Chinese 'bribes', GSK; UK Serious Fraud Office; Financial Times;,GSK UK Serious Fraud Office Financial Times,2023-03-31 11:20:43.299057,No
6659,1475487,GSK.L,2014-05-29,2014-05-28, GSK;,GSK staff seek reimbursement for 'bribes' paid out of own pockets, GSK; UK Serious Fraud Office; Financial Times;,GSK UK Serious Fraud Office Financial Times,2023-03-31 11:20:52.562632,No
6660,1475845,GSK.L,2014-06-02,2014-06-01, GSK;,GSK in $350m oncology deal," GSK; Merck & Co,;",GSK Merck Co,2023-03-31 11:21:01.722647,No
6661,1478733,GSK.L,2014-06-30,2014-06-29, GSK;,Sex tape adds to murk of GSK China scandal, GSK; US;,GSK US,2023-03-31 11:21:10.856162,No
6662,1479214,GSK.L,2014-07-04,2014-07-03, GSK;,Private eye facing China trial attacks GSK, British; UK; Financial Times; GSK; US;,British UK Financial Times GSK US,2023-03-31 11:21:20.067140,No
6663,1480133,GSK.L,2014-07-17,2014-07-16, GSK;,GSK admits to 2001 China bribery scandal, US; GSK; Financial Times; US Department of Justice; Morrison & Foerster;,US GSK Financial Times US Department of Justice Morrison Foerster,2023-03-31 11:21:29.830866,No
6664,1480196,GSK.L,2014-07-17,2014-07-16, GSK;,GSK admits 2001 bribe scandal, US; GSK; Financial Times; US Department of Justice; Morrison & Foerster;,US GSK Financial Times US Department of Justice Morrison Foerster,2023-03-31 11:21:39.061275,No
6665,1480994,GSK.L,2014-07-24,2014-07-23, GSK;,Long-time GSK favourite stumbles in the final furlong, GSK;,GSK,2023-03-31 11:21:48.228164,No
6666,1481114,GSK.L,2014-07-28,2014-07-27, GSK;,Witty comes out fighting GSK's corner, US; GSK; Swiss; Pfizer; US Department of Justice; UK Serious Fraud Office; China;,US GSK Swiss Pfizer US Department of Justice UK Serious Fraud Office China,2023-03-31 11:21:57.556672,No
6667,1481942,GSK.L,2014-08-04,2014-08-03, GSK;,Buyout groups eye $10bn bid for older brands of GSK and Sanofi, KKR; US; GSK; Abbott Laboratories; Lazard;,KKR US GSK Abbott Laboratories Lazard,2023-03-31 11:22:06.772648,No
6668,1486330,GSK.L,2014-09-25,2014-09-24, GSK;,RBS chairman Hampton poised to take the helm at GlaxoSmithKline, Royal Bank; UK; GSK; RBS; Citizens; US; Lloyds TSB; British Telecom; Standard Life;,Royal Bank UK GSK RBS Citizens US Lloyds TSB British Telecom Standard Life,2023-03-31 11:22:16.013742,No
6669,1499994,GSK.L,2015-02-27,2015-02-26, GSK;,"Witty's GSK pay cut to 3.9m after China corruption scandal and sales of drugs
fall", US; GSK; China; US Department of Justice;,US GSK China US Department of Justice,2023-03-31 11:22:25.156991,No
6670,1506081,GSK.L,2015-05-07,2015-05-06, GSK;,Medicine man: Witty rules out big drug deal for GSK, UK; US; GSK;,UK US GSK,2023-03-31 11:22:34.268706,No
6671,1506546,GSK.L,2015-05-11,2015-05-10, GSK;,GlaxoSmithKline chief seeks immunity from sector's herd mentality, US; GSK; Standard & Poor; BDX;,US GSK Standard Poor BDX,2023-03-31 11:22:43.483072,No
6672,1506607,GSK.L,2015-05-12,2015-05-11, GSK;,GSK's Witty warns over 'artificial high' inflating $460bn drugs deal boom, Financial Times; US; UK; GSK;,Financial Times US UK GSK,2023-03-31 11:22:52.640297,No
6673,1513623,GSK.L,2015-07-30,2015-07-29, GSK;,GSK: hype the pipe, GSK;,GSK,2023-03-31 11:23:01.783751,No
6674,1513856,GSK.L,2015-08-04,2015-08-03, GSK;,GSK rehires suspected whistleblower as China bribery saga takes new twist, UK; GSK; UK Serious Fraud Office; US; Vivian; Financial Times;,UK GSK UK Serious Fraud Office US Vivian Financial Times,2023-03-31 11:23:10.994894,No
6675,1522954,GSK.L,2015-11-18,2015-11-17, GSK;,GSK chief's prudence unlikely to win much credit from markets, US; Johnson; Pfizer; Merck; GSK;,US Johnson Pfizer Merck GSK,2023-03-31 11:23:20.145999,No
6676,1529083,GSK.L,2016-02-04,2016-02-03, GSK;,GSK: stabilising, GSK;,GSK,2023-03-31 11:23:29.291067,No
6677,1533194,GSK.L,2016-03-18,2016-03-17, GSK;,Rio teaches a succession lesson dawdling GSK would do well to heed, FTSE; GSK;,FTSE GSK,2023-03-31 11:23:38.457273,No
6678,1533241,GSK.L,2016-03-18,2016-03-17, GSK;,GSK: wheel of fortune, FTSE; Pfizer; GSK;,FTSE Pfizer GSK,2023-03-31 11:23:47.582300,No
6679,1533258,GSK.L,2016-03-18,2016-03-17, GSK;,Witty defends GSK structure to the end as exit sparks speculation over break-up, Financial Times; US; White House; GSK;,Financial Times US White House GSK,2023-03-31 11:23:53.598678,No
6680,1534015,GSK.L,2016-04-01,2016-03-31, GSK;,GSK raises developing world access to its drugs by allowing low-cost copies, UK; GSK; World Bank; Group;,UK GSK World Bank Group,2023-03-31 11:23:59.561270,No
6681,1544366,GSK.L,2016-08-02,2016-08-01, GSK;,GSK joins Alphabet to develop 'third way' of bioelectronic disease control, Verily Life Sciences; Google Life Sciences; GSK; UK;,Verily Life Sciences Google Life Sciences GSK UK,2023-03-31 11:24:08.748939,No
6682,1547845,GSK.L,2016-09-21,2016-09-20, GSK;,GSK picks consumer head Walmsley to succeed Witty as chief executive, GSK;,GSK,2023-03-31 11:24:17.891674,No
6683,1566008,GSK.L,2017-04-27,2017-04-26, GSK;,GlaxoSmithKline: continuity candidate, GSK;,GSK,2023-03-31 11:24:27.051203,No
6684,1567091,GSK.L,2017-05-12,2017-05-11, GSK;,GSK buoyed by air delay, US Food and Drug Administration; FDA; GSK;,US Food and Drug Administration FDA GSK,2023-03-31 11:24:36.235249,No
6685,1595134,GSK.L,2017-10-27,2017-10-26, GSK;,London GSK hits 18-month low following fears over dividend, Merrill Lynch; Merrill; GSK; US; BNP Paribas; US Marketplace; National Express; JD Sports; Nike; Sirius Minerals; PT Chemical Indonesia;,Merrill Lynch Merrill GSK US BNP Paribas US Marketplace National Express JD Sports Nike Sirius Minerals PT Chemical Indonesia,2023-03-31 11:24:45.617876,No
